US › Healthcare

Bone Biologics Corp (BBLG)

US · Healthcare · Biotechnology

$0.95+5.01%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-765,988

Profit YoY

+24.7%

EPS

$-0.43

EPS estimate

$-0.54

EPS came in at -0.43 against a street estimate of -0.54 — a beat of 20.4%.

Key statistics

Market cap

$1.6M

Forward P/E

0.0

P/B

0.33

Book value

$2.60

EPS (TTM)

$-1.16

52-week high

$4.13

52-week low

$0.83

50-day MA

$1.26

200-day MA

$1.48

Beta

0.53

Analyst view

Analysts rate Bone Biologics Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.20.

Shareholding

Insiders

0.04%

Institutions

0.25%

Largest institutional holders

Fund	Stake
Clear Street Group Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Bone Biologics Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.